Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biondvax Pharma ADR (NQ: BVXV ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biondvax Pharma ADR < Previous 1 2 3 4 5 6 7 8 Next > The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL March 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 06, 2022 Gainers ContraFect (NASDAQ:CFRX) stock in... Via Benzinga Aegis Capital Corp. Acted as Sole Bookrunner on a $9.8 Million Underwritten Public Offering of ADSs for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) January 03, 2022 NEW YORK, NY / ACCESSWIRE / January 3, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $9.8 Million Underwritten Public Offering of ADSs for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV). About... From Aegis Capital Corp. Via AccessWire 18 Stocks Moving in Friday's Pre-Market Session December 31, 2021 Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares. Xeris... Via Benzinga 63 Biggest Movers From Yesterday December 31, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its... Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session December 30, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future... Via Benzinga 20 Stocks Moving in Thursday's Pre-Market Session December 30, 2021 Gainers BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 33.6% to $3.10 in pre-market trading. BiondVax reported successful closing of $9.8 million follow-on underwritten... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 29, 2021 Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is... Via Benzinga 45 Biggest Movers From Yesterday December 29, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy... Via Benzinga 25 Stocks Moving In Tuesday's Mid-Day Session December 28, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE... Via Benzinga Mid-Morning Market Update: Markets Mostly Higher; Digital Turbine Reports Multi-Year Collaboration With Google December 28, 2021 Following the market opening Tuesday, the Dow traded up 0.48% to 36,476.04 while the NASDAQ fell 0.13% to 15,850.57. The S&P also rose, gaining 0.10% to 4,795.90. The U.S. has... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 28, 2021 Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1... Via Benzinga Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher December 27, 2021 Toward the end of trading Monday, the Dow traded up 0.64% to 36,181.37 while the NASDAQ rose 1.19% to 15,838.88. The S&P also rose, gaining 1.07% to 4,776.31. The U.S. has the... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session December 27, 2021 Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%... Via Benzinga 51 Biggest Movers From Yesterday December 28, 2021 Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to... Via Benzinga Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge December 27, 2021 Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92. The U.S. has the... Via Benzinga 34 Stocks Moving In Monday's Mid-Day Session December 27, 2021 Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY... Via Benzinga Mid-Morning Market Update: Markets Open Higher; News Corp To Buy Base Chemicals December 27, 2021 Following the market opening Monday, the Dow traded up 0.39% to 36,089.53 while the NASDAQ rose 0.78% to 15,774.78. The S&P also rose, gaining 0.70% to 4,758.97. The U.S. has... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 27, 2021 Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million... Via Benzinga 15 Stocks Moving in Monday's Pre-Market Session December 27, 2021 15 stocks that should be interesting to investors. Via Talk Markets 15 Stocks Moving in Monday's Pre-Market Session December 27, 2021 Gainers IceCure Medical Ltd (NASDAQ: ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering... Via Benzinga The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus December 26, 2021 Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... Via Talk Markets The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year December 26, 2021 Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 23, 2021 Gainers Pasithea Therapeutics (NASDAQ: Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session December 23, 2021 Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 23, 2021 Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares... Via Benzinga 18 Stocks Moving in Thursday's Pre-Market Session December 23, 2021 Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 22, 2021 Gainers BioCardia (NASDAQ:BCDA) shares ro... Via Benzinga Why BiondVax Shares Are Soaring Today December 22, 2021 BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) is trading higher Wednesday after the company announced it signed definitive agreements for the development and commercialization... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 22, 2021 Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.